HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nestlé makes Atrium move

This article was originally published in OTC Bulletin & The Rose Sheet

Executive Summary

Nestlé has signalled its intention to become a force in consumer healthcare by acquiring Canadian supplements specialist Atrium Innovations for US$2.3 billion (€1.95 billion) from a group of investors led by Permira Funds. Subject to regulatory approval, the transaction is expected to close in the first quarter of 2018.

You may also be interested in...



Nestlé Developing Microbiome-Based Supplements with Dutch Partner

Nestlé Health Science is putting its financial weight behind the Netherlands' Caelus Health to help commercialize microbiome-based food supplements for early intervention in a number of diseases.

Hershey's Latest Sweet Spot In Nutritional Space: $397m For One Brands

Marketer long known for iconic Hershey's Kisses and other candy products looks to grow its nutritional market revenues with One Brands' products, complementing its Oatmega business and following its investment earlier in August in UK/Ireland maker of protein bars.

Nestlé Grows Health Offering With Global Deal for Anti-Aging Supplement

In line with its nutrition, health and wellness strategy, Nestlé has bolstered its consumer health offering with ChromaDex’ innovative energy boosting supplement.

Topics

UsernamePublicRestriction

Register

RS121881

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel